FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Lexington, Kentucky park shooting kills 1, injures 4 during live band performance

Last-Ditch Effort to Kill Trump Fossil Fuel EOs Goes Down in Flames

Family killer Chris Watts seeks prison marriage with new love interest: report

Why Did Pollsters Get Michigan And Wisconsin Primaries So Wrong?

Jon Ossoff, Georgia’s first Jewish senator, faces angry Jewish voters

Trump’s men at the United Nations

Swing-state’s fraud reckoning raises Minnesota-style alarm as wild schemes exposed

Mundane DOJ Memo on Post Office Gun Bans Is Actually Bigger Deal Than You Think

ICE bought nonlethal shock gloves for officers. Democrats still are not pleased

Americans clash over transgender athletes as debate heats up: ‘Just getting outrageous’

Routine California traffic stop leads to seizure of 30 pounds of cocaine worth more than $800K

New Report Says Chinese Cameras Used in Naval Assets Secretly Sent Data to Communist Country

Alaska runner hospitalized after using bear spray to fight off brown bear on Alaska trail

Nevada man funneled 140 guns to violent Mexican drug cartels, including powerful ‘military-style’ rifles: DOJ

Ex-detective who served fraction of 102-year sentence faces new charges after cold case review

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”